About THERYQ

Located in the South of France, THERYQ is an innovative medical technology company specializing in the design and production of radiotherapy machines incorporating linear accelerators. The company masters and provides essential expertise on project management, R&D, industrialization and manufacturing. THERYQ is part of ALCEN For Health, the healthcare branch of the ALCEN group.

The focus of our technology is to translate FLASH radiotherapy from laboratory to clinical practice. Currently in the pre-clinical research stage, our goal is to:

• Develop solutions to increase patients’ opportunities to be cured of cancer
• Decrease direct and indirect treatment costs
• Offer clinicians devices capable of more efficient treatments for improved patient outcomes

THERYQ is a spin-off of the company PMB-ALCEN, which led the pioneering projects on FLASH Radiotherapy since 2013 and has a long-standing collaboration with several prominent institutions around the world. In 2022, PMB transferred the complete branch of activity dedicated to radiotherapy to THERYQ.